Having Trouble Breathing?
Participating in a COPD Clinical Trial Might Be Able to Help You!
Chronic obstructive pulmonary disease (COPD) is a progressive, inflammatory lung condition that makes it difficult to breathe. It includes chronic bronchitis and emphysema and is often caused by long-term exposure to harmful particles or gases, most commonly from smoking. Symptoms typically include shortness of breath, persistent cough, mucus production, and wheezing. While it primarily affects older adults, early symptoms can appear years before diagnosis.
According to the CDC, over 16 million Americans have been diagnosed with COPD, though millions more may have it without knowing. In individuals with COPD, the airways become narrowed and inflamed, leading to airflow obstruction and reduced lung function. This can result in decreased quality of life, limited physical activity, and increased risk of complications like lung infections.
If you or someone you know has COPD, Revival Research Institute is currently conducting COPD Clinical Trials to explore potential new treatment options.
Are You Eligible to Participate?
To qualify for the chronic obstructive pulmonary disease (COPD) Clinical Trials, participants must be:
- 18 years or older
- A former/current smoker
- Diagnosed with COPD
*Additional criteria may apply.
Participation in the COPD Clinical Trials is free of cost. To learn more or enroll, fill out the form below. A member of our research team will contact you to discuss your potential eligibility for the study.
About Chronic Obstructive Pulmonary Disease Clinical Trials
COPD can significantly affect your quality of life. Persistent shortness of breath, chronic cough, and fatigue can interfere with sleep, limit daily activities, and make even simple tasks feel exhausting. The ongoing struggle to breathe may lead to anxiety, social withdrawal, and frequent hospital visits, further disrupting personal independence and emotional well-being. Studies show that COPD patients often experience anxiety or depression, which are linked to reduced quality of life, increased emergency visits, and more frequent or longer hospitalizations
Revival Research Institute is conducting a clinical trial for individuals with moderate to severe COPD. This study aims to evaluate the safety and effectiveness of an investigational treatment that may help reduce symptoms such as breathing difficulty, lung inflammation, and flare-ups.
Clinical trials are being conducted at multiple locations across the United States, including Michigan. To participate, individuals must complete a screening process and agree to all study procedures. Eligible participants will receive either the investigational treatment or a placebo, and all study-related care is provided at no cost.
*All study procedures and study-related treatments, including the investigational drug, are provided at no cost, and no insurance is required to participate, and participants may receive compensation for time and travel.
*To take the next step, submit the form above, and our research staff will contact you to determine if you qualify for the study. A brief discussion about your health and medical history may be required.
Get Started
What to Expect?
If you are living with Chronic Obstructive Pulmonary Disease (COPD), you may qualify for a paid clinical trial exploring new treatment options. After completing the interest form above, someone from our research team will contact you for a brief pre-screening to determine if you meet the initial eligibility criteria.
If you qualify, you’ll be asked to review and sign an Informed Consent Form (ICF), which outlines all study procedures, potential benefits, and possible risks. Once consent is given, you will be invited to one of Revival’s research sites for a screening visit. During this visit, we will review your medical history, conduct physical exams, and perform lab tests to further assess your eligibility. If you meet all study requirements, you will be officially enrolled in the COPD Clinical Trial.
Our team is committed to ensuring you fully understand your role in the study and what to expect throughout the trial. Please feel free to ask any questions before deciding to participate. Your involvement helps advance future treatment options for COPD.
Age
Condition
Location
Chronic Obstructive Pulmonary Disease (COPD)

Don’t Let Shortness of Breath Slow You Down
Chronic obstructive pulmonary disease is a common, progressive lung condition that makes breathing increasingly difficult over time. It typically results from long-term exposure to irritants such as cigarette smoke, air pollution, or workplace fumes.
COPD doesn’t just affect the lungs—it impacts independence, physical activity, sleep, and emotional well-being. Many individuals experience flare-ups triggered by respiratory infections, cold air, or environmental irritants, often leading to emergency care or hospitalization. Although inhalers and medications may offer relief, many still struggle to manage symptoms in the long term.
If you or a loved one has COPD and is seeking new options, Revival Research Institute is conducting COPD Clinical Trials. These studies aim to evaluate investigational treatments that may help improve lung function and quality of life.
COPD May Be Triggered By
- Cigarette smoke
- Cold air or weather changes
- Respiratory infections like colds or the flu
- Air pollutants & fumes
- Dust, mold, or allergens
Common Symptoms of COPD Include
- Shortness of breath, especially during physical activity
- Chronic cough that doesn’t go away
- Excess mucus or phlegm production
- Wheezing or a whistling sound when breathing
- Chest tightness or discomfort
Frequently Asked Questions
Your Guide to Chronic Obstructive Pulmonary Disease (COPD)
Got questions about COPD? You’re not alone.
We’ve compiled answers to some of the most common questions about COPD—what causes it, how it’s managed, and what daily life with the condition can look like. Still can’t find what you’re looking for? Our team is here to help. Call us on +1 (248) 721-9539, and we’ll be happy to assist you.
What is COPD?
COPD is a chronic inflammatory lung disease that affects the airway. The airways get blocked because of exposure to air pollutants, passive smoking, and genetic factors. As a result of which it gets harder to breathe.
Will I have to pay for the COPD Clinical Trials?
No, participation is completely free in Revival Research Institute’s COPD Clinical Trials, and your health insurance is not required. Instead, as a participant, you may be compensated for your time and travel.
What is the purpose of clinical trials for COPD?
The sole purpose of conducting COPD Clinical Trials is to assess the efficacy and safety of the investigational medication that may be able to help advance medicine and help doctors understand the condition and potential treatment options. We aim to make novel treatment options accessible through clinical trials that may be able to help you and countless others.
How long does a COPD exacerbation last?
COPD exacerbation might last for days or even weeks depending on the severity. Marked variation is evident in individuals. It may require the use of antibiotics, corticosteroids, and even hospitalization.
What are the stages of COPD?
There are four phases of chronic obstructive pulmonary disease (COPD): mild, moderate, severe, and very severe. Your physician will decide which stage you fall under by carrying out some breathing tests including spirometry. This method decides your lung efficacy by estimating how much air can be taken in and out.


